Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19
Published
Published
TechX Technologies Inc (CSE:TECX) has entered into a debt settlement agreement pursuant to which the company has agreed to issue..
The government revised the clinical guidance for COVID-19 treatment, dropping the off-label use of convalescent plasma as it was..